TAHO PHARMACEUTICALS LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.3 TWD | -13.21% |
|
-0.43% | -.--% |
| 1 day | -13.21% |
| Managers | Title | Age | Since |
|---|---|---|---|
Howard Lee
CEO | Chief Executive Officer | 62 | 10/14/10 |
Frank Tung
BRD | Director/Board Member | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Chih Kang Ke
BRD | Director/Board Member | - | - |
Howard Lee
CEO | Chief Executive Officer | 62 | 10/14/10 |
Shih Liang Liu
BRD | Director/Board Member | - | 27/14/27 |
TAHO Pharmaceuticals Ltd. is a Taiwan-based company principally engaged in the sales of medical equipment. The Company is also involved in the development of drugs, as well as the sales of health care products. The Company has also developed a new oral release film formulation, TAH4411, through its Transepithelia Delivery System (TDS). The Company distributes its products mainly in domestic market.
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 0 | |
| +29.05% | 42.68B | |
| -3.02% | 42.4B | |
| +45.32% | 40.04B | |
| -6.20% | 28.31B | |
| +7.45% | 24.94B | |
| -20.71% | 18.96B | |
| +28.63% | 12.3B | |
| -2.34% | 11.95B | |
| -1.53% | 11.55B |
- Stock Market
- Equities
- 6467 Stock
